Pre-Market Earnings Report for March 28, 2025 : HUMA, IPA, SLE
From Nasdaq: 2025-03-27 16:00:00
- Humacyte, Inc. (HUMA) is expected to report earnings for the quarter ending December 31, 2024, with a consensus forecast of $-0.23 per share, a 4.17% increase from the same quarter last year. The stock’s Price to Earnings ratio for 2024 is -1.57, indicating potential for higher earnings growth compared to industry competitors.
- ImmunoPrecise Antibodies Ltd. (IPA) is set to report earnings for the quarter ending January 31, 2025, with a consensus forecast of $-0.06 per share, a 25.00% increase from the same quarter last year. The stock’s Price to Earnings ratio for 2025 is -1.58, contrasting with an industry ratio of 7.30.
- Super League Enterprise, Inc. (SLE) will report earnings for the quarter ending December 31, 2024, with a consensus forecast of $-0.35 per share, an 89.91% increase from the same quarter last year. The stock’s Price to Earnings ratio for 2024 is -0.18, signaling potential for higher earnings growth compared to industry competitors.
Read more at Nasdaq:: Pre-Market Earnings Report for March 28, 2025 : HUMA, IPA, SLE